Anhui Huangshan Capsule Co., Ltd. Logo

Anhui Huangshan Capsule Co., Ltd.

002817.SZ

(2.8)
Stock Price

6,24 CNY

5.38% ROA

6.26% ROE

34.21x PER

Market Cap.

1.935.164.060,00 CNY

6.3% DER

1.31% Yield

12.88% NPM

Anhui Huangshan Capsule Co., Ltd. Stock Analysis

Anhui Huangshan Capsule Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Anhui Huangshan Capsule Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (1%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Net Profit Growth

The net profit of this company has steadily increased over the last five years, showcasing a favorable financial performance and making it an enticing option for investors seeking growth potential.

3 Dividend

With a solid track record of dividend payments over the past five years, the company has established itself as a dependable choice for investors seeking consistent income.

4 ROE

The stock's ROE falls within an average range (7.77%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (6.23%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

6 PBV

The stock's PBV ratio (2.94x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

7 Revenue Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

8 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (55) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

9 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

10 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

11 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

Anhui Huangshan Capsule Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Anhui Huangshan Capsule Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Anhui Huangshan Capsule Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Anhui Huangshan Capsule Co., Ltd. Revenue
Year Revenue Growth
2011 189.446.728
2012 244.009.476 22.36%
2013 268.953.187 9.27%
2014 273.413.371 1.63%
2015 253.790.897 -7.73%
2016 283.435.099 10.46%
2017 285.955.869 0.88%
2018 294.709.587 2.97%
2019 325.557.296 9.48%
2020 319.426.287 -1.92%
2021 379.891.008 15.92%
2022 428.318.791 11.31%
2023 399.298.970 -7.27%
2023 458.369.373 12.89%
2024 462.340.140 0.86%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Anhui Huangshan Capsule Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2011 0
2012 7.910.400 100%
2013 6.734.124 -17.47%
2014 7.973.525 15.54%
2015 9.453.459 15.65%
2016 8.964.112 -5.46%
2017 10.374.490 13.59%
2018 13.139.290 21.04%
2019 12.774.858 -2.85%
2020 9.348.494 -36.65%
2021 13.439.131 30.44%
2022 14.980.970 10.29%
2023 10.060.956 -48.9%
2023 14.067.792 28.48%
2024 10.440.656 -34.74%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Anhui Huangshan Capsule Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2011 18.547.999
2012 18.272.781 -1.51%
2013 4.507.503 -305.39%
2014 4.048.183 -11.35%
2015 4.837.084 16.31%
2016 7.469.814 35.24%
2017 8.723.409 14.37%
2018 7.215.792 -20.89%
2019 9.362.754 22.93%
2020 7.000.354 -33.75%
2021 8.405.978 16.72%
2022 7.780.684 -8.04%
2023 62.296.251 87.51%
2023 8.691.884 -616.72%
2024 -9.599.607 190.54%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Anhui Huangshan Capsule Co., Ltd. EBITDA
Year EBITDA Growth
2011 47.498.198
2012 57.370.553 17.21%
2013 67.140.925 14.55%
2014 71.515.994 6.12%
2015 73.356.357 2.51%
2016 79.496.103 7.72%
2017 78.572.515 -1.18%
2018 65.639.166 -19.7%
2019 70.490.348 6.88%
2020 76.492.164 7.85%
2021 93.372.218 18.08%
2022 103.014.924 9.36%
2023 73.360.780 -40.42%
2023 100.437.030 26.96%
2024 95.588.120 -5.07%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Anhui Huangshan Capsule Co., Ltd. Gross Profit
Year Gross Profit Growth
2011 77.555.391
2012 101.813.658 23.83%
2013 106.207.455 4.14%
2014 110.295.120 3.71%
2015 112.855.988 2.27%
2016 120.905.291 6.66%
2017 102.946.515 -17.44%
2018 98.083.030 -4.96%
2019 117.832.945 16.76%
2020 101.744.025 -15.81%
2021 121.568.544 16.31%
2022 117.009.622 -3.9%
2023 113.112.370 -3.45%
2023 123.248.984 8.22%
2024 109.270.280 -12.79%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Anhui Huangshan Capsule Co., Ltd. Net Profit
Year Net Profit Growth
2011 37.344.848
2012 47.936.678 22.1%
2013 47.983.298 0.1%
2014 51.761.105 7.3%
2015 54.890.458 5.7%
2016 52.284.781 -4.98%
2017 46.420.390 -12.63%
2018 35.966.208 -29.07%
2019 39.130.702 8.09%
2020 45.255.710 13.53%
2021 56.887.811 20.45%
2022 60.850.372 6.51%
2023 68.568.873 11.26%
2023 64.863.467 -5.71%
2024 57.421.196 -12.96%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Anhui Huangshan Capsule Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Anhui Huangshan Capsule Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2011 15.147.331
2012 27.163.751 44.24%
2013 -20.130.861 234.94%
2014 12.853.089 256.62%
2015 17.334.284 25.85%
2016 16.089.189 -7.74%
2017 16.953.509 5.1%
2018 -5.723.439 396.21%
2019 27.319.331 120.95%
2020 -31.068.271 187.93%
2021 10.250.081 403.1%
2022 48.884.625 79.03%
2023 93.351.663 47.63%
2023 62.611.610 -49.1%
2024 3.724.567 -1581.04%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Anhui Huangshan Capsule Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2011 22.936.300
2012 65.695.800 65.09%
2013 23.126.725 -184.07%
2014 52.066.505 55.58%
2015 40.324.017 -29.12%
2016 32.526.938 -23.97%
2017 44.423.824 26.78%
2018 27.523.879 -61.4%
2019 52.028.243 47.1%
2020 62.711.557 17.04%
2021 86.089.406 27.16%
2022 83.016.820 -3.7%
2023 99.934.045 16.93%
2023 63.742.828 -56.78%
2024 7.089.201 -799.15%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Anhui Huangshan Capsule Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2011 7.788.968
2012 38.532.049 79.79%
2013 43.257.586 10.92%
2014 39.213.416 -10.31%
2015 22.989.732 -70.57%
2016 16.437.749 -39.86%
2017 27.470.314 40.16%
2018 33.247.318 17.38%
2019 24.708.912 -34.56%
2020 93.779.828 73.65%
2021 75.839.324 -23.66%
2022 34.132.194 -122.19%
2023 6.582.382 -418.54%
2023 1.131.218 -481.88%
2024 3.364.634 66.38%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Anhui Huangshan Capsule Co., Ltd. Equity
Year Equity Growth
2011 149.426.323
2012 197.363.001 24.29%
2013 236.766.299 16.64%
2014 278.777.405 15.07%
2015 323.917.863 13.94%
2016 630.950.274 48.66%
2017 666.103.565 5.28%
2018 696.589.644 4.38%
2019 726.325.302 4.09%
2020 765.149.741 5.07%
2021 809.975.466 5.53%
2022 854.210.235 5.18%
2023 901.114.795 5.21%
2023 891.815.881 -1.04%
2024 905.649.222 1.53%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Anhui Huangshan Capsule Co., Ltd. Assets
Year Assets Growth
2011 198.152.328
2012 263.823.660 24.89%
2013 326.070.055 19.09%
2014 349.994.759 6.84%
2015 412.997.214 15.25%
2016 699.357.647 40.95%
2017 738.732.768 5.33%
2018 780.034.833 5.29%
2019 831.803.641 6.22%
2020 915.812.091 9.17%
2021 1.053.820.293 13.1%
2022 1.037.692.058 -1.55%
2023 1.103.085.111 5.93%
2023 1.108.915.262 0.53%
2024 1.069.086.465 -3.73%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Anhui Huangshan Capsule Co., Ltd. Liabilities
Year Liabilities Growth
2011 48.726.004
2012 66.460.658 26.68%
2013 89.303.756 25.58%
2014 71.217.354 -25.4%
2015 89.079.351 20.05%
2016 68.407.372 -30.22%
2017 72.629.202 5.81%
2018 83.445.188 12.96%
2019 105.478.337 20.89%
2020 150.662.349 29.99%
2021 243.844.826 38.21%
2022 183.481.821 -32.9%
2023 171.875.734 -6.75%
2023 217.099.381 20.83%
2024 147.925.226 -46.76%

Anhui Huangshan Capsule Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1.47
Net Income per Share
0.19
Price to Earning Ratio
34.21x
Price To Sales Ratio
4.41x
POCF Ratio
22.79
PFCF Ratio
25.86
Price to Book Ratio
2.14
EV to Sales
4.22
EV Over EBITDA
23.86
EV to Operating CashFlow
21.85
EV to FreeCashFlow
24.79
Earnings Yield
0.03
FreeCashFlow Yield
0.04
Market Cap
1,94 Bil.
Enterprise Value
1,86 Bil.
Graham Number
3.59
Graham NetNet
0.58

Income Statement Metrics

Net Income per Share
0.19
Income Quality
1.5
ROE
0.06
Return On Assets
0.05
Return On Capital Employed
0.05
Net Income per EBT
0.87
EBT Per Ebit
1.32
Ebit per Revenue
0.11
Effective Tax Rate
0.12

Margins

Sales, General, & Administrative to Revenue
0.02
Research & Developement to Revenue
0.03
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.25
Operating Profit Margin
0.11
Pretax Profit Margin
0.15
Net Profit Margin
0.13

Dividends

Dividend Yield
0.01
Dividend Yield %
1.31
Payout Ratio
0.77
Dividend Per Share
0.09

Operating Metrics

Operating Cashflow per Share
0.28
Free CashFlow per Share
0.25
Capex to Operating CashFlow
0.12
Capex to Revenue
0.02
Capex to Depreciation
0.87
Return on Invested Capital
0.04
Return on Tangible Assets
0.05
Days Sales Outstanding
140.62
Days Payables Outstanding
72.93
Days of Inventory on Hand
126.56
Receivables Turnover
2.6
Payables Turnover
5
Inventory Turnover
2.88
Capex per Share
0.03

Balance Sheet

Cash per Share
0,46
Book Value per Share
3,08
Tangible Book Value per Share
3.02
Shareholders Equity per Share
3.03
Interest Debt per Share
0.19
Debt to Equity
0.06
Debt to Assets
0.05
Net Debt to EBITDA
-1.03
Current Ratio
3.13
Tangible Asset Value
0,90 Bil.
Net Current Asset Value
0,27 Bil.
Invested Capital
642640530
Working Capital
0,29 Bil.
Intangibles to Total Assets
0.02
Average Receivables
0,18 Bil.
Average Payables
0,06 Bil.
Average Inventory
115371558
Debt to Market Cap
0.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Anhui Huangshan Capsule Co., Ltd. Dividends
Year Dividends Growth
2017 0
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Anhui Huangshan Capsule Co., Ltd. Profile

About Anhui Huangshan Capsule Co., Ltd.

Anhui Huangshan Capsule Co., Ltd. manufactures and sells hollow and enteric hollow capsules in China. It offers entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colon soluble vacant gelatin capsules, hydroxypropyl methyl cellulose and hydroxypropyl starch hollow capsules, and pulluan capsules. The company was founded in 1989 and is based in Xuancheng, China.

CEO
Mr. Chao Biao Yu
Employee
681
Address
No. 7 Huangjia Avenue
Xuancheng, 242600

Anhui Huangshan Capsule Co., Ltd. Executives & BODs

Anhui Huangshan Capsule Co., Ltd. Executives & BODs
# Name Age
1 Mr. Chao Biao Yu
GM & Director
70
2 Ms. Xue Dong
Accounting Supervisor
70
3 Mr. Song Lin Ye
Deputy General Manager
70
4 Mr. Xian Li Xiang
Deputy GM & Secretary of the Board
70

Anhui Huangshan Capsule Co., Ltd. Competitors